DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Quingestrone
Quingestrone
Pharmaceutical Appendix to the Tariff Schedule 2
50 Years of Oral Lipid-Based Formulations: Provenance, Progress and Future Perspectives
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
1111111111111111111Imnumu
Stembook 2018.Pdf
Reproductive Health Guideline Appendix 3 – Search Strategies
Wo 2009/015286 A2
(12) Patent Application Publication (10) Pub. No.: US 2004/019870.6 A1 Carrara Et Al
(12) United States Patent (10) Patent No.: US 7,199,151 B2 Shashoua Et Al
Council of Europe Committee of Ministers (Partial
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2009/0118236A1 Erion Et Al
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Composition and Methods for Transdermal Delivery Of
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Transdermal Device Containing
Customs Tariff - Schedule Xxi - 1
Wo 2007/044693 A2
Top View
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
Resolution Ap (77) 1
(12) Patent Application Publication (10) Pub. No.: US 2003/0027804 A1 Van Der Hoop (43) Pub
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
Transdermal Device Containing Polyvinylpyrrolidone As Solubility Enhancer
Combinations of Droloxifene with Progestins for the Treatment of Osteoporosis
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
1111111111111111111Imnumu
Ep 2283865 A1
(12) Patent Application Publication (10) Pub. No.: US 2011/0245215 A1 Carrara Et Al
(12) Patent Application Publication (10) Pub. No.: US 2008/0103116 A1 Jennings-Spring (43) Pub
Clinical Studies with Oral Lipid Based Formulations of Poorly Soluble Compounds
XII. Birth Control A
WO 2007/016766 Al
Antineoplastic Drugs